ISRG · Large Cap · NASDAQ · Healthcare · Medical Instruments & Supplies
Free AI brief
Free to track. No card required. Usually ready in 10-15 minutes.
Price, momentum, and the numbers behind the story.
Stocksbrew score
66/100
See the full financial picture
Open the five-year record, valuation checks and Wall Street view behind these scores.
Free for 3 days, then $9/mo. Cancel anytime.
Where the analysts and the crowd stand, and what it's worth to know first.
Lowest
$324
Current price
$398.99
Median target
$483
Highest
$685
What it earns and where it earns it, what you're paying for the stock, and the risk sitting on the balance sheet.
ROIC
Strong · Excellent capital returns
21.9%
ROE
Favorable · 17.2% - solid capital efficiency
17.4%
Debt / equity
Favorable · 0.00 - strong leverage
-
Current ratio
Strong · Good liquidity position
4.96x
Forward P/E
Needs attention · 87% above avg
34.81x
Price / sales
Rich · Overpriced by revenue
12.59x
Price / FCF
Rich · Expensive vs. cash flow
43.12x
EV / EBITDA
Rich · Earnings can't support price
31.99x
ISRG against the names it's actually compared to.
| Company | Mkt cap | P/E | Rev growth | Score |
|---|---|---|---|---|
| $138.95B | 45.1 | +20.7% | 66 | |
| $9.95B | 18.9 | +19.7% | 78 | |
| $33.72B | 35.3 | +15.5% | 78 | |
| $4.12B | 12.4 | +13.5% | 78 | |
| $1.09T | 39.2 | +49.6% | 77 |
Every story that touched the stock this week, newest first.